A brain training trial finds a reduction in dementia diagnoses after 20 years -- but for a very specific kind of training.

New research into oral GLP-1 medications for diabetes and -- perhaps further down the track -- weight loss.

And risk factors for developing an allergy. Some well known, others more peculiar.

References

• Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study
• Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3)
• Risk factors for the development of food allergy in infants and children